[ad_1]

Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *